Allogene Therapeutics, Inc. Share Price
NASDAQ: ALLO | Micro CapAllogene Therapeutics, Inc. Stock Performance
Allogene Therapeutics, Inc. Share Price Today
As of 31 October 2026, Allogene Therapeutics, Inc.'s share price is $1.18. The stock opened at $1.25, compared to its previous close of $1.26. During today's trading session, Allogene Therapeutics, Inc.'s share price traded between $1.17 and $1.25, with an average price of $1.21. Over the past 52 weeks, the stock has recorded a high of $4.45 and a low of $1.04. In terms of performance, Allogene Therapeutics, Inc.'s share price has declined by 44.71% over the last six months and is down 4.86% on a year-on-year basis.
Allogene Therapeutics, Inc. Share Price Chart
Allogene Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Allogene Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Allogene Therapeutics, Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Allogene Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.59 | $1.18 | -25.87% |
Sep 2026 | $1.99 | $1.58 | -24.34% |
Aug 2026 | $1.87 | $2.10 | +12.03% |
Jul 2026 | $2.05 | $1.87 | -9.88% |
Jun 2026 | $2.18 | $2.08 | -5.03% |
May 2026 | $2.09 | $2.19 | +2.82% |
Apr 2026 | $2.50 | $2.13 | -12.91% |
Mar 2026 | $2.67 | $2.44 | -12.54% |
Feb 2026 | $1.80 | $2.79 | +51.63% |
Jan 2026 | $1.35 | $1.84 | +34.80% |
Dec 2025 | $1.45 | $1.36 | -5.86% |
Nov 2025 | $1.26 | $1.45 | +17.41% |